Incidence of Neonatal Herpes Simplex Virus Infections in U.S. 15.7 Per 100,000 Births in 2019
By Elana Gotkine HealthDay Reporter
TUESDAY, April 15, 2025 -- The incidence of neonatal herpes simplex virus (nHSV) infections in the United States in 2019 was 15.7 per 100,000 hospital births, according to a study published online April 14 in Pediatrics.
Matthew Pooser, from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estimated the incidence, costs, and fatality of nHSV in 2019 by assessing a nationally representative sample of U.S. pediatric discharges using data from the Healthcare Cost and Utilization Project Kids' Inpatient Database. Estimates were generated overall and by sociodemographic factors. Cases were estimated among infants aged 28 days or younger admitted to the hospital.
The researchers identified an estimated 561 nHSV cases in the United States in 2019, for an incidence rate of 15.7 per 100,000 hospital births. The incidence rate was highest in the South (21.3) and among infants born to Black birth parents (27.3). The estimated total cost to the U.S. health care system was $28.9 million. Among infants with nHSV, the case fatality rate was estimated to be 4.6 percent.
"We found an increase in the incidence of nHSV and costs to the health care system compared with past estimates; however, the case fatality rate did not substantially change," the authors write. "Our findings also highlight racial and geographic disparities."
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-16 06:00
Read more

- Longtime Head of 9/11 Health Program Let Go Amid Federal Job Cuts
- Pregnant Women, New Moms Dying More Often From Heart Conditions
- FDA Approves Imfinzi (durvalumab) for Muscle Invasive Bladder Cancer
- Icotrokinra Results Show 75% of Adolescents with Plaque Psoriasis Achieved Completely Clear Skin and Demonstrate Favorable Safety Profile in a Once Daily Pill
- Air Pollution May Contribute to Skin Health Issues
- FDA Announces 'Operation Stork Speed' to Improve Infant Formula
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions